←Back to list

VitriVax

Thermostable single-dose vaccine platform (ALTA); lead Lyme disease vaccine
VitriVax (Boulder, United States) — thermostable single-dose vaccine platform (ALTA); lead Lyme disease vaccine. On November 18, 2026 it announced a $87M Series C, led by F-Prime, NEA, RA Capital Management, Sanofi Ventures. Funds take the Lyme vaccine to first-in-human trials. Prior: $17.25M Series B (Sep/Oct 2025). Total-raised figures conflict between sources.
Biotech 📍 Boulder
Current Valuation
Private
PRIVATE

IPO Outlookprivate

Is VitriVax going public?
No. VitriVax is private and has not filed to go public. There is no S-1 on file.
What is VitriVax's valuation in 2026?
No confirmed valuation is on record for VitriVax. The roster shows funding and investors where they are public; it does not estimate a mark.
Has VitriVax filed an S-1?
No public S-1 is on file for VitriVax.
Who are VitriVax's investors?
VitriVax's investors include F-Prime, NEA, RA Capital Management, Sanofi Ventures, Eli Lilly.
Is VitriVax publicly traded — can you buy VitriVax stock?
No. VitriVax is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for VitriVax on its Pre-IPO Access Desk.
How to actually get exposure to VitriVax →
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.

Company Profile

HQ
Boulder
Last Round
Series C — $87M (Nov 2026) · Lead: F-Prime / NEA / RA Capital Management / Sanofi Ventures
IPO Status
private

Fundraising Status

Series C · $87M · this month
private1 disclosed rounds

Funding History

RoundAmountDateLead InvestorPost-Money
Series C$87MNov 2026F-Prime / NEA / RA Capital Management / Sanofi Ventures—

Recent Activity

💰
Nov 2026 · citybiz · funding

Vertical Intelligence — Biotech / Gene Therapy

Biotech / Gene Therapy registry data for VitriVax has not been collected yet — the weekly vertical sweep hasn't reached this company. Check back soon.

Talent Signal

Hiring data for VitriVax has not been collected yet — the monthly talent sweep hasn't reached this company. Check back soon.

Investors

F-Prime · NEA · RA Capital Management · Sanofi Ventures · Eli Lilly
BiotechThermostable single-dose vaccines
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of recent date. Refreshed quarterly.